Fujian Cosunter Pharmaceutical Co (SZSE:300436) Other Operating Expense : ¥103.8 Mil (TTM As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is Fujian Cosunter Pharmaceutical Co Other Operating Expense?

Fujian Cosunter Pharmaceutical Co's Other Operating Expense for the three months ended in Mar. 2025 was ¥-0.1 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was ¥103.8 Mil.

Fujian Cosunter Pharmaceutical Co's quarterly Other Operating Expense increased from Sep. 2024 (¥-67.3 Mil) to Dec. 2024 (¥114.9 Mil) but then declined from Dec. 2024 (¥114.9 Mil) to Mar. 2025 (¥-0.1 Mil).

Fujian Cosunter Pharmaceutical Co's annual Other Operating Expense increased from Dec. 2022 (¥111.5 Mil) to Dec. 2023 (¥124.9 Mil) but then declined from Dec. 2023 (¥124.9 Mil) to Dec. 2024 (¥103.1 Mil).

Fujian Cosunter Pharmaceutical Co Other Operating Expense Historical Data

The historical data trend for Fujian Cosunter Pharmaceutical Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fujian Cosunter Pharmaceutical Co Other Operating Expense Chart

Fujian Cosunter Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Operating Expense

Get a 7-Day Free Trial

57.36

80.52

111.48

124.92

103.05

Fujian Cosunter Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Operating Expense	Get a 7-Day Free Trial															-0.81	56.25	-67.32	114.93	-0.05

Fujian Cosunter Pharmaceutical Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥103.8 Mil.

Fujian Cosunter Pharmaceutical Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Fujian Cosunter Pharmaceutical Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Fujian Cosunter Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fujian Cosunter Pharmaceutical Co Ltd (SZSE:300436) » Definitions » Other Operating Expense

Traded in Other Exchanges

N/A

Address

Software Park, No. 89, Software Avenue, Block B, Building 10, Zone B, Gulou District, Fujian, Fuzhou, CHN, 350003

Website

http://www.cosunter.com

Fujian Cosunter Pharmaceutical Co Ltd is a pharmaceutical company engaged in the pharmaceutical production, sales and Research and Development. Its specialized in the field of hepatitis B medicine. Its product includes Fuganding-tenofovir disoproxil fumarate capsule, Enganding-Entecavir Capsules, He Ganding-Lamifuzed tablets and Agandan-adefovir dipivoxil tablets.

Executives

Li Guo Ping	Directors, executives
Huang Fu Hu	Directors, executives
Li Hong Ming	Directors, executives
Guan Jian Hui	Executives
Lin Xiao Hui	Directors, Directors, and Executives
Ye Li Qing	Director
Li Yuan Li	Supervisors
Zheng Li Feng	Supervisors
Li Guo Dong	Directors, executives

Fujian Cosunter Pharmaceutical Co Headlines

No Headlines